NCT03216954View on ClinicalTrials.gov

Influence of n-Acetylcysteine Maintenance on Alcohol Effects

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

September 15, 2017

Primary Completion Date

April 23, 2020

Study Completion Date

April 23, 2020

Conditions
Alcohol Use Disorder
Interventions
DRUG

Alcohol

During each arm, subjects will receive doses of alcohol, designed to raise BALs to 0.015 and 0.03 g/dl.

DRUG

Placebos

Subjects will receive placebo capsules

DRUG

N-acetyl cysteine

Subjects will receive n-acetyl cysteine capsules

Trial Locations (1)

40507

University of Kentucky, Lexington

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

William Stoops

OTHER

NCT03216954 - Influence of n-Acetylcysteine Maintenance on Alcohol Effects | Biotech Hunter | Biotech Hunter